1.16
+0.7445(+179.18%)
Currency In USD
| Previous Close | 0.42 |
| Open | 1.26 |
| Day High | 1.39 |
| Day Low | 0.97 |
| 52-Week High | 3.65 |
| 52-Week Low | 0.37 |
| Volume | 376.83M |
| Average Volume | 531,587 |
| Market Cap | 7.69M |
| PE | -0.84 |
| EPS | -1.38 |
| Moving Average 50 Days | 0.85 |
| Moving Average 200 Days | 0.92 |
| Change | 0.74 |
If you invested $1000 in Imunon, Inc. (IMNN) 10 years ago, it would be worth $2.11 as of May 25, 2025 at a share price of $1.16. Whereas If you bought $1000 worth of Imunon, Inc. (IMNN) shares 5 years ago, it would be worth $25.61 as of May 25, 2025 at a share price of $1.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
May 23, 2025 10:59 PM GMT
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage c
IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer
GlobeNewswire Inc.
May 23, 2025 12:05 PM GMT
Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group Women treated with IMNN-001 and standard of care chemotherapy plus PARP inh
IMUNON Announces Withdrawal of Form S-1 Registration Statement
GlobeNewswire Inc.
May 22, 2025 9:20 PM GMT
LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities a